miR-29c-3p acts as a tumor promoter by regulating β-catenin signaling through suppressing DNMT3A, TET1 and HBP1 in ovarian carcinoma
Authors:
- 3 November 2023
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 113, 110936
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Development Fund (2022ZY0208)
- National Natural Science Foundation of China (31960162)
- Government of Inner Mongolia Autonomous Region (NJZY23134)
This publication has 100 references indexed in Scilit:
- miR-29 Represses the Activities of DNA Methyltransferases and DNA DemethylasesInternational Journal of Molecular Sciences, 2013
- Structural Insights into RNA Recognition by RIG-ICell, 2011
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2Nature, 2010
- Recognition of 5′ Triphosphate by RIG-I Helicase Requires Short Blunt Double-Stranded RNA as Contained in Panhandle of Negative-Strand VirusImmunity, 2009
- The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platformGynecologic Oncology, 2009
- The Epigenomics of CancerCell, 2007
- MicroRNA expression profiles classify human cancersNature, 2005
- A microRNA polycistron as a potential human oncogeneNature, 2005
- The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001